Tesamorelin CAS:218949-48-5

 

Tesamorelin (tes" a moe rel' in) is a synthetic 44 amino acid polypeptide analogue of growth hormone releasing hormone (GHRH). The N terminal portion of the molecule has been modified to improve its stability and pharmacokinetics in comparison to native GHRH. Tesamorelin activates GHRH receptors in the pituitary which leads to synthesis and release of growth hormone that acts on multiple cells of the body including hepatocytes where it stimulates production of insulin like growth factor-1 (IGF-1). IGF-1 mediates many of the effects of growth hormone, which in the liver include growth, inhibition of programmed cell death, glucose update and lipolysis. Serum IGF-1 levels tend to be low in patients with obesity, diabetes and particularly in those with lipodystrophy. Tesamorelin was evaluated and found to be effective in decreasing visceral adiposity in patients with lipodystrophy associated with antiretroviral therapy of human immunodeficiency virus (HIV) infection. Tesamorelin was approved for use in the United States as therapy to reduce excess abdominal fat in HIV-infected patients with antiviral therapy-related lipodystrophy in 2010.

 

 

 

Once Tesamorelin is inside the human body, the peptide binds to GHRH receptors to stimulate the pituitary gland into releasing growth hormone at a rate similar to the body's naturally occurring GHRH traveling through the bloodstream. Once more growth hormone is released, it boosts metabolism and improves muscle growth, which helps to burn more calories and decrease body fat. The peptide can also help to increase insulin growth factor (IGF-1), which can help to lower glucose levels and further stimulate weight loss. As a result, Tesamorelin can help reduce visceral adipose tissue, leading to improved belly appearance, size, and waist circumference.

 

 

Because Tesamorelin can help stimulate human growth hormone production, patients can experience several benefits from using Tesamorelin for fat loss, such as:

● Significant IGF-1 increase

● Reduced visceral fat

● Increased muscle mass

● Reduced liver fat

● Improved cardiovascular health

● Reduced LDL cholesterol

● Improved cognitive function

● Accelerated recovery time after workouts

Tesamorelin can also produce notable improvements in cognitive function for healthy adults and seniors with early signs of dementia. The peptide can also improve lipid profile and cardiovascular health by decreasing the intima-media thickness of the carotid arteries, which can help prevent atherosclerotic vascular disease.

 

 

Tesamorelin is typically sold in powder form and needs to be mixed with water before it can be used as an injection. Before mixing the treatment, store the needles, syringes, and the box of sterile water used for injection at room temperature. Because Tesamorelin is a highly fragile peptide, you will need to mix it gently in sterilized water for optimal dilution. Once it has been reconstituted into a liquid form, you will need to store the mixture in the refrigerator for the recommended duration of treatment. Always store your Tesamorelin out of reach of children or any pets you may have. You will also need to keep the box of medication in a place away from direct light. You should always check the medication to make sure that it hasn't changed colors or has particles in it. If that occurs, discard the medication and call your physician for a new prescription.

Tesamorelin injections are typically given subcutaneously under the skin of your stomach once a day. When picking the injection site, choose a place below the belly button and avoid any area that may have scar tissue, bruises, reddening, and irritation. Make sure to clean the injection site with rubbing alcohol before injecting each dose. You should also rotate the injection site each time to avoid any redness or irritation after the injection.

 

 

Product Name	Egrifta SV, INN
CAS	218949-48-5
Molar mass	5135.86
MF	C221H366N72O67S
Capacity/Bottle	2mg/vial
Shape	Lyophilized powder

 

Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885

 

 

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It is primarily used for medical purposes rather than bodybuilding, and its approved medical use is to treat a specific condition known as lipodystrophy in people living with HIV.

Lipodystrophy is a medical condition characterized by abnormal fat distribution in the body. People with HIV who are treated with certain antiretroviral medications may develop lipodystrophy, which can involve fat loss from certain areas of the body (such as the face, arms, and legs) and fat accumulation in other areas (such as the abdomen or neck).

Tesamorelin works by stimulating the release of growth hormone from the pituitary gland. In the context of treating lipodystrophy in people with HIV, it is used to address the unwanted fat accumulation, particularly in the abdominal area. The goal is to reduce visceral adipose tissue (fat around the organs) and improve the overall appearance and metabolic health of individuals affected by this condition.

In bodybuilding or athletic contexts, some individuals have used growth hormone-releasing peptides like tesamorelin with the belief that they may promote muscle growth, fat loss, or performance enhancement. However, the use of tesamorelin or similar peptides for these purposes is not approved by regulatory authorities, and its efficacy and safety for bodybuilding or athletic performance have not been well-established through scientific research.

If you are interested in bodybuilding or improving your athletic performance, it is advisable to focus on evidence-based approaches such as proper nutrition, strength training, cardiovascular exercise, and recovery strategies. Consult with a healthcare provider or sports medicine specialist for guidance on achieving your fitness goals safely and effectively.

 

Hot Tags: tesamorelin cas:218949-48-5, China tesamorelin cas:218949-48-5 manufacturers, suppliers, factory